Dr. Dean is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12040 Ne 128th St
Kirkland, WA 98034Phone+1 425-899-3181
Education & Training
- University of California (San Francisco)Fellowship, Hematology and Medical Oncology, 2008 - 2011
- University of California (San Francisco)Residency, Internal Medicine, 2005 - 2008
- Harvard Medical SchoolClass of 2005
Certifications & Licensure
- CA State Medical License 2007 - Present
- WA State Medical License 2015 - 2026
Clinical Trials
- Lenalidomide and Rituximab in Subjects With Previously Untreated Indolent Non-Hodgkin's Lymphoma Start of enrollment: 2010 Dec 01
- Phase II Study to Evaluate Overall Response in Patients With Higher Risk Myelodysplastic Syndromes (MDS) Treated With Azacitidine With or Without Deferasirox. Start of enrollment: 2014 Sep 11
Publications & Presentations
PubMed
- 19 citationsA Meta-analysis of Multiple Myeloma Risk Regions in African and European Ancestry Populations Identifies Putatively Functional Loci.Kristin A. Rand, Chi Song, Eric Dean, Daniel J. Serie, Karen Curtin
Cancer Epidemiology, Biomarkers & Prevention. 2016-12-01
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: